- Sale of privately held US pharmaceutical / drug delivery company
- Identified qualified potential acquirers of US NASDAQ company
- Concluded out-licensing assignment for privately held US company
- Strategic advisory and business development role introducing new technology relevant to major pharma R&D processes
- Brokered research alliance between above client and NIH
- Performed US market assessment for UK based supportive oncology therapy
- Provide marketing and commercial input to UK company’s oncology pipeline
- Analyzed and advised on commercialization options for potentially unique range of antimicrobial drug candidates
- Identified EU based outlicensing partners for US company’s lead product
- Identified steps to secure late stage US pharmaceutical products for UK company
- International marketing partner for Transatlantic Business Conference in New York and London
- Co-founders of new international medical society
- Designed and implemented commercial development plan for oncology product
- Advised N. American public company on EU regulatory plan for new in-licensed product
PRODUCT & BUSINESS DEVELOPMENT, CLINICAL STRATEGY, MARKETING & COMMUNICATIONS, INTERIM MANAGEMENT…